Herbalife Reports 7.8% Net Sales Increase to $1.317 Billion in Q1 2026

Herbalife Ltd. reported a net sales increase of 7.8% for the first quarter of 2026, reaching $1.317 billion compared to $1.222 billion in the same period of 2025. The growth was attributed to a 4.1% rise in sales volume and a 3.2% positive impact from price increases, despite a 2.1% unfavorable sales mix. The company's net income attributable to Herbalife also rose by 22.8% to $61.9 million, or $0.57 per diluted share, up from $50.4 million, or $0.49 per diluted share, in the prior year.

In terms of operational metrics, the company saw a significant increase in cash and cash equivalents, which rose to $451.2 million from $353.1 million at the end of 2025. Herbalife's total assets increased to $2.875 billion, up from $2.786 billion, while total liabilities also rose slightly to $3.309 billion from $3.295 billion. The company’s shareholders' deficit improved to $434.2 million from $509.4 million, reflecting a reduction in the accumulated deficit and an increase in paid-in capital.

Geographically, the Asia Pacific region, excluding China, experienced the most substantial growth, with net sales increasing by 17.3% to $495.8 million. Latin America also saw a notable increase of 17.1%, driven by favorable foreign exchange rates and price increases. Conversely, sales in China decreased by 12.0% to $57.0 million, primarily due to a significant drop in sales volume. The company continues to focus on enhancing its digital capabilities and customer loyalty programs in this region.

Strategically, Herbalife made significant moves in the first quarter, including the acquisition of assets from Pruvit Ventures and Pro2col Health, which are expected to enhance its product offerings in personalized nutrition. Additionally, the company entered into a $55 million asset purchase agreement with Bioniq, a personalized supplements company, which includes contingent payments based on sales milestones. These acquisitions align with Herbalife's strategy to expand its product portfolio and enhance its market presence.

Looking ahead, Herbalife remains cautious about the macroeconomic environment, including inflation and geopolitical tensions, which could impact its operations. The company plans to continue monitoring these factors while focusing on its growth strategies, including product innovation and market penetration. The management expressed confidence in its ability to navigate these challenges and maintain operational efficiency, supported by a strong cash position and ongoing investments in technology and infrastructure.